TENX
TENAX THERAPEUTICS, INC.
Next earnings Aug 11, 2026 · consensus $-0.39 EPS
Last earnings +1.8% on 2026-05-12
$12.89
▼ -0.31%$12.89▲ +122.63%
over 1Y
L $5.62EODHDH $18.27
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-0.3%
1W+7.4%
1M+7.6%
3M-13.9%
YTD+16.7%
1Y+122.6%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 12 analysts
Strong Buy
Conservative balance sheet (liabilities/equity 0.07x).
TENAX THERAPEUTICS, INC. shows $0.00 in FY2025 revenue, and -54.2% ROE.
Sources: SEC EDGAR (CIK 0000034956, latest 10-Q filed 2026-05-12) · EODHD · as of 6/26/2026, 12:45:05 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.